SUPPORTING OUR PROVIDER PARTNERS THROUGH COMMUNICATION AND COLLABORATION.
DATE MARCH 2011 ISSUE 1
Visit Our Online Searchable Formularies!
HELPFUL NUMBERS FOR PROVIDERS
Passport Health Plan PerformRx: (800) 578-0898 Bin: 600428 Processor control: 02920000
Trying to find out if a prescription is covered by Passport Health Plan (PHP) or Passport Advantage (PAD)? Visit our online searchable formularies! is electronic application is updated frequently and allows you to search for the most current covered drugs by name or therapeutic class.
PHP: www.passporthealthplan.com/apps/formulary PAD: www.passportadvantage.org/apps/formulary/2011
Passport Advantage PerformRx: (866) 533-5490 Bin: 012353 Processor control: 03650000 Injectables: (866) 533-5490,
Medicaid-Covered Diabetic Supplies Now Processed Through Pharmacy
HELPFUL NUMBERS FOR MEMBERS
Recently, the Kentucky Department for Medicaid Services limited the processing of certain diabetic supplies to the pharmacy point-of-sale (POS) system.
Passport Health Plan 1-800-578-0603, option #2
Passport Advantage 1-800-578-0603, option #1
NEW IN THIS ISSUE
Reminder: Controlled Substance Claims Denied for Prescribers Not Enrolled in Kentucky Medicaid
Minimizing the Risk for Drug-Drug Interactions
ESRD Drugs Excluded from Medicare Part D
March 2011 Change to Plan Formularies on ePOCRATES®
PHP OTC List Updated
© 2011 PASSPORT HEALTH PL AN
Effective March 1, 2011, Passport Health Plan (PHP) will mirror this state requirement and the diabetic supplies listed below will no longer be available through Durable Medical Equipment (DME) providers.
ese supplies will only be covered through the pharmacy with a valid
Pharmacies may see an increase in the number of PHP members presenting for the following diabetic supplies:
• • • •
Blood glucose meters Blood glucose test strips Calibration Solutions Insulin syringes
Urine test or reagent strips
Blood ketone test or reagent strips
All medications may be subject to edits to limit quantities dispensed, days’ suppl , and drug-drug interactions at the point of service. Appropriate diagnosis, drug therapy length and approved indications will be used in determining medical necessity.
Committee decisions are based upon relevant medical literature that is evidence based, peer reviewed, and English language based, using appropriate study designs.
Price(s) listed are AWP from First Data Bank as of 01-20-2006. ese are displayed as a reference only and intended to be a learning tool for providers for the costs of therapy prescribed for a one-month period unless otherwise indicated. Prices are calculated from AWP using the lower dose strengths applicable to therapy for 30-day supply calculated.